2021-01-08,Oppenheimer: These 3 Stocks Could Spike Over 80%
2020-12-17,miRagen Enters into License Agreement with Xencor for use of Xtend Antibody Technology for Investigational Antibodies to Treat Thyroid Eye Disease
2020-11-10,miRagen Reports Third Quarter 2020 Financial Results and Provides Corporate Updates
2020-11-10,"Arena (ARNA) Q3 Earnings Top, Stock Down on Eczema Study Data"
2020-11-09,"Iovance (IOVA) Q3 Earnings Beat Estimates, Pipeline in Focus"
2020-11-06,"Sarepta (SRPT) Q3 Loss Widens Y/Y, Revenues Beat Estimates"
2020-11-06,"Clovis (CLVS) Q3 Earnings Top, Sales Show Coronavirus Impact"
2020-10-28,Looking Into Miragen Therapeutics's Return On Capital Employed
2020-10-28,"miRagen Therapeutics, Inc. Announces Acquisition of Viridian Therapeutics, Inc."
2020-10-05,miRagen Announces Internal Review of Preliminary Topline Data for the Phase 2 SOLAR Clinical Trial of Cobomarsen in Patients with Cutaneous T-Cell Lymphoma (CTCL)
2020-09-14,miRagen Announces Leadership Transition and Review of Strategic Alternatives
2020-08-24,How Should Investors React To Miragen Therapeutics' (NASDAQ:MGEN) CEO Pay?
2020-08-20,miRagen Announces Results of Meeting With FDA Regarding the Design of Pivotal Trial for Cobomarsen in ATLL
2020-08-05,"Signal Genetics, Inc. (MGEN) Reports Q2 Loss, Misses Revenue Estimates"
2020-08-05,miRagen Reports Second Quarter 2020 Financial Results and Provides Business Updates
2020-08-04,miRagen to Present at the 2020 Wedbush PacGrow Healthcare Virtual Conference
2020-07-29,"Will Signal Genetics, Inc. (MGEN) Report Negative Earnings Next Week? What You Should Know"
2020-07-28,"miRagen, Investigators from Goethe University and University Hospital Frankfurt and Servier Publish MRG-110 Phase 1 Pharmacodynamic Biomarker Data  in Nucleic Acid Therapeutics"
2020-07-23,Cobomarsen Receives Orphan Drug Designation From the U.S. FDA for the Treatment of T-cell Lymphoma
2020-07-22,"miRagen to Report Second Quarter 2020 Financial Results on August 5, 2020"
2020-07-02,miRagen Regains Compliance With Nasdaq Listing Requirements
2020-06-23,"The Daily Biotech Pulse: Sanofi Expedites COVID-19 Vaccine Timeline, Apyx Cleared For Market Expansion, Miragen's Positive Readout"
2020-06-22,miRagen Announces Encouraging Preclinical Safety and Efficacy Data for its Next-generation miR-29 Replacement Product Candidate Intended for the Treatment of Idiopathic Pulmonary Fibrosis
2020-06-19,"The Daily Biotech Pulse: Tiziana Snags A Patent Win, Decision Day For Nabriva And Evoke, IPOs"
2020-06-18,miRagen Strengthens Leadership Team with Appointment of Lee Rauch as Chief Operating Officer
2020-06-18,"Company News for Jun 18, 2020"
2020-06-16,"miRagen to Host a Key Opinion Leader Call on Idiopathic Pulmonary Fibrosis on Tuesday, June 23rd"
2020-06-04,Hedge Funds Arent Crazy About Miragen Therapeutics (MGEN)
2020-05-27,3 Strong Buy Biotech Stocks Under $5 With Explosive Upside Potential
2020-05-26,miRagen to Present at the Jefferies 2020 Virtual Global Healthcare Conference
2020-05-12,Did Changing Sentiment Drive Miragen Therapeutics' (NASDAQ:MGEN) Share Price Down A Painful 94%?
2020-05-07,miRagen Reports First Quarter 2020 Financial Results and Provides Corporate Update
2020-04-30,"Signal Genetics, Inc. (MGEN) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release"
2020-04-23,"miRagen Therapeutics to Report First Quarter 2020 Financial Results On May 7, 2020"
2020-03-13,"Analysts Have Lowered Expectations For Miragen Therapeutics, Inc. After Its Latest Results"
2020-03-11,"Signal Genetics, Inc. (MGEN) Reports Q4 Loss, Lags Revenue Estimates"
2020-03-11,miRagen Reports Fourth Quarter and Full Year 2019 Financial Results
2020-03-11,"Miragen Therapeutics, Inc. to Host Earnings Call"
2020-03-04,"Signal Genetics, Inc. (MGEN) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release"
2020-02-20,"miRagen Therapeutics to Report Fourth Quarter and Full Year 2019 Financial Results on March 11, 2020"
2020-02-14,Has Signal Genetics (MGEN) Outpaced Other Medical Stocks This Year?
2020-02-07,miRagen Announces Pricing of $15.0 Million Public Offering of Common Stock and Warrants to Purchase Common Stock
2020-02-06,miRagen Announces Proposed Public Offering of Common Stock and Warrants to Purchase Common Stock
2020-01-31,"Company News for Jan 31, 2020"
2020-01-30,miRagen Therapeutics Announces Positive Data for Cobomarsen in Adult T-Cell Leukemia/lymphoma Patients With Residual Disease
2020-01-23,miRagen Therapeutics to Present New Cobomarsen Clinical Trial Data for Adult T-Cell Leukemia/Lymphoma at Two Upcoming Conferences
2019-12-13,"The Daily Biotech Pulse: Second Time's The Charm For Sarepta, Pfizer's Xeljanz Snags Third Approval, NewLink Genetics Rejects Competing Offer"
2019-12-12,"The Daily Biotech Pulse: European Nod For Amgen, miRagen Overhauls Clinical Pipeline, Tonix Snags Patent Win"
2019-12-11,miRagen Announces Major Changes to Companys Strategy
2019-11-26,miRagen to Present at the Evercore ISI HealthCONx Conference 2019
2019-11-12,"Could Miragen Therapeutics, Inc.'s (NASDAQ:MGEN) Investor Composition Influence The Stock Price?"
2019-11-07,"Signal Genetics, Inc. (MGEN) Reports Q3 Loss, Lags Revenue Estimates"
2019-11-07,miRagen Reports Third Quarter 2019 Results and Provides Corporate Update
2019-10-31,"Earnings Preview: Signal Genetics, Inc. (MGEN) Q3 Earnings Expected to Decline"
2019-10-28,miRagen to Present at the DIA/FDA Oligonucleotide-Based Therapeutics Conference Today
2019-10-22,miRagen Therapeutics to Report Third Quarter 2019 Financial Results and Host a Conference Call
2019-10-16,miRagen Announces New Clinical Data Showing MRG-110 Positively Impacted Tissue Repair and New Blood Vessel Growth
2019-08-15,miRagen Therapeutics to Present a Corporate Overview at the Robert W. Baird & Co. 2019 Global Healthcare Conference
2019-08-12,miRagen Therapeutics to Present a Corporate Overview at the 2019 Wedbush Healthcare Conference
2019-08-07,"Signal Genetics, Inc. (MGEN) Reports Q2 Loss, Tops Revenue Estimates"
2019-08-07,miRagen Reports Second Quarter 2019 Results; Regains Global Rights to MRG-110 and Announces Corporate Restructuring
2019-07-31,"Analysts Estimate Signal Genetics, Inc. (MGEN) to Report a Decline in Earnings: What to Look Out for"
2019-07-24,Miragen Therapeutics to Report Second Quarter 2019 Financial Results and Host a Conference Call on August 7th
2019-06-21,Some Miragen Therapeutics (NASDAQ:MGEN) Shareholders Have Copped A Big 66% Share Price Drop
2019-05-28,miRagen Therapeutics to Present a Corporate Overview at the Jefferies 2019 Global Healthcare Conference
2019-05-21,miRagen Presents Preclinical Data in Pulmonary Fibrosis Using Second Generation microRNA-29 Replacement Product Candidate at the 2019 American Thoracic Society International Conference
2019-05-08,"Signal Genetics, Inc. (MGEN) Reports Q1 Loss, Misses Revenue Estimates"
2019-05-08,miRagen Announces First Quarter 2019 Financial Results and Provides Corporate Update
2019-05-01,"Earnings Preview: Signal Genetics, Inc. (MGEN) Q1 Earnings Expected to Decline"
2019-04-29,miRagen Therapeutics Announces New Data Supporting the Potential Use of Remlarsen to Prevent Corneal Fibrosis at the 2019 ARVO Meeting
2019-04-28,"Can We See Significant Institutional Ownership On The Miragen Therapeutics, Inc. (NASDAQ:MGEN) Share Register?"
2019-04-26,"miRagen Announces New Clinical Data for Cobomarsen in ATLL Patients at the 19th Annual HTLV Congress in Lima, Peru"
2019-04-25,miRagen Therapeutics to Report First Quarter 2019 Financial Results and Host a Conference Call on May 8th
2019-03-14,"Miragen Therapeutics Inc (MGEN) Files 10-K for the Fiscal Year Ended on December 31, 2018"
2019-03-13,"Signal Genetics, Inc. (MGEN) Reports Q4 Loss, Misses Revenue Estimates"
2019-03-13,miRagen Announces Fourth Quarter and Full Year 2018 Financial Results and Provides 2019 Outlook
2019-03-06,miRagen Therapeutics to Present a Corporate Overview at the 29th Annual Oppenheimer & Co. Healthcare Conference
2019-02-20,miRagen Therapeutics to Report Fourth Quarter and Fiscal 2018 Financial Results and Host a Conference Call on March 13th
2019-01-24,"Colorado biotech firms are developing drugs to fight cancer, help children and cut down on excessive sweating"
2019-01-10,miRagen Announces New Clinical Data in Patients With Three Different Types of Blood Cancers Treated With Cobomarsen
2018-12-20,miRagen Therapeutics to Present New Cobomarsen Clinical Trial Data for Adult T-Cell Leukemia/Lymphoma and Cutaneous T-Cell Lymphoma at the 11th Annual T-Cell Lymphoma Forum
2018-12-18,"Hedge Funds Are Crazy About Miragen Therapeutics, Inc. (MGEN)"
2018-12-05,miRagen Therapeutics Announces Board of Director Evolution and Appointment of New Chairman
2018-12-02,"miRagen Therapeutics Announces Final Safety, Biodistribution and Clinical Efficacy Data From Phase 1 Cobomarsen Clinical Trial in Patients With Mycosis Fungoides"
2018-11-07,"Signal Genetics, Inc. (MGEN) Reports Q3 Loss, Misses Revenue Estimates"
2018-11-07,miRagen Therapeutics Reports Third Quarter 2018 Financial Results and Provides Corporate Update
2018-11-01,Miragen Therapeutics to Present New Cobomarsen Phase 1 Clinical Trial Data at the 2018 American Society of Hematology Annual Meeting
2018-10-29,miRagen Therapeutics to Present at two Investor Conferences in November 2018
2018-10-24,"miRagen Therapeutics to Report Third Quarter 2018 Financial Results and Host Conference Call on November 7, 2018"
2018-10-01,"miRagen Therapeutics Announces the Presentation of Data From Preclinical Studies Demonstrating the Potential Anti-Fibrotic Effect of Remlarsen in the Cornea at the 2018 OLIGO Meeting in Seattle, WA"
2018-08-07,miRagen Therapeutics Reports Second Quarter 2018 Financial Results and Provides Corporate Update
2018-08-07,"Miragen Therapeutics, Inc. to Host Earnings Call"
2018-08-06,miRagen Therapeutics and The Leukemia & Lymphoma Society® Enter Into an Agreement to Facilitate the Development of Cobomarsen in Cutaneous T-Cell Lymphoma
2018-07-31,miRagen Therapeutics to Present at the 2018 Wedbush PacGrow Healthcare Conference
2018-07-25,"miRagen Therapeutics to Report Second Quarter 2018 Financial Results and Host Conference Call on August 7, 2018"
2018-07-10,miRagen Therapeutics Announces Initiation of Phase 2 Clinical Trial of MRG-201
2018-07-03,Gaithersburg biotech raising $1M to stop cancer tumors in their tracks
2018-06-04,Miragen Therapeutics to Present First Cobomarsen Phase 1 Clinical Trial Data From Patients With Adult T-Cell Leukemia/lymphoma and New Interim Data From Patients With Mycosis Fungoides at the 2018 American Society of Clinical Oncology Annual Meeting
2018-05-31,"miRagen Therapeutics to Present at Jefferies 2018 Global Healthcare Conference on Thursday, June 7th"
2018-05-16,miRagen Therapeutics to Present New Interim Data From Phase 1 Clinical Trial of Cobomarsen at the 2018 American Society of Clinical Oncology Annual Meeting
